Cyberonics wins FDA nod for AspireSR

Cyberonics (NSDQ:CYBX) said it won FDA approval for its AspireSR generator designed for vagus nerve stimulation to treat drug-resistant epilepsy. VNS is approved by the FDA to treat epilepsy by delivering electrical signals to the vagus nerve, which project to areas of the brain associated with seizures. Studies have shown a majority of drug-resistent epileptic […] The post Cyberonics wins FDA nod for AspireSR appeared first on MassDevice.
Source: Mass Device - Category: Medical Equipment Authors: Tags: Food & Drug Administration (FDA) mm Neurological Regulatory/Compliance AspireSR Epilepsy Source Type: news